Gregory Maes

Business Development & Innovation Manager | Personalized Liquid Biopsy | Democratizing Healthcare | Biotech Entrepreneur/Consultant

[Gregory Maes @GregBioGenomics]

🎉! Hiring Alert 2023! 🎉

🛎 It's an exciting time to join the @NonacusLtd team! We are rapidly growing 🚀 and need more colleagues to help us achieve our global expansion 🌍 !
Go check our open positions here: https://t.co/DJLps43AZE

[OncoDaily @oncodaily]

Great EACR Liquid Biopsies 2024 meeting - @GregBioGenomics
@EACRnews

https://t.co/PBttkZby9h

#Cancer #LiquidBiopsy #CancerResearch #PrecisionMedicine #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

[OncoDaily @oncodaily]

Bladder cancer educational factsheets - @GregBioGenomics
@WorldBladderCan

https://t.co/XbTxydO5nu

#Cancer #OncoDaily #Oncology #BladderCancer #MedEd #MedX #MedNews #Medicine

[OncoDaily @oncodaily]

Liquid biopsy for non-invasive cancer detection - @GregBioGenomics

https://t.co/KDezZDEY4J

#Cancer #LiquidBiopsy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

[Gregory Maes @GregBioGenomics]

@manuelvera07 @ANECAinfo_ @PilarPaneque Congrats!!

[Gregory Maes @GregBioGenomics]

Bupa launches first genetic test for bladder cancer for policyholders https://t.co/pyX4ELSTAI via @cover_mag

[Nonacus @NonacusLtd]

This #bloodcancerawarenessmonth we want to highlight the realities for patients in the U.K and the importance of streamlining testing. Click the link to find out how Nonacus is collaborating with a leading genomics testing hub to tackle these issues:

https://t.co/ZUQ4Jb5fwt

[Nonacus @NonacusLtd]

Introducing a special Lunch & Learn with customer success story by Professor Tim Aitman on the use of Nonacus Custom Panels

-Weds 13th Sept
-1:10-3:00 PM
-University of Edinburgh, Institute of Genetics and Cancer, S1.14 Room

Please RSVP to [email protected]

[Gregory Maes @GregBioGenomics]

@bossuyt_wouter @cole_soryy @LeibfarthGroup A student shot his supervisor in that lab yesterday @bossuyt_wouter, got arrested little time later.... Law enforcement was looking for the shooter

[Nonacus @NonacusLtd]

What makes an ideal MRD marker for Acute Myeloid Leukemia? Features include:

✓ Exclusively present within the AML-defining clone
✓ Absent (or nearly absent) in the preleukemic state
✓ Correlates with therapeutic response
✓ Recurs at disease relapse

https://t.co/3wW8ulvEpn

[Gregory Maes @GregBioGenomics]

@eshgsociety Upstairs too! 💃🕺🥳

[European Society of Human Genetics (ESHG) @eshgsociety]

@eshgsociety is in full party mode! Enjoy the night everyone #eshg2023. See you tomorrow for more #Genetics...

[Gregory Maes @GregBioGenomics]

Great venue, concert and party @PacBio! 👌🥐🥳🕺💃

[Neil Ward @GenomicsUK]

@PacBio hope you all enjoyed our #ESHG2023 party. Retweet if you think we should do something like this again in Berlin!

[Nature Reviews Genetics @NatureRevGenet]

Transitioning single-cell genomics into the clinic https://t.co/V0G4OLokHu #Perspective by @drjenlim, @chin_venessa, @FairfaxKirsten, @Moutinho_C, Dan Suan, Hanlee Ji & @drjosephpowell @GarvanInstitute @CellularFutures @kinghorncancer @UNSW @UTAS_ @StanfordMed @Stanford

[Gregory Maes @GregBioGenomics]

@neyts_johan @KU_Leuven @PeterLievens @PasteurDakar @hadjalahbib Well done @neyts_johan and @astrivax team! Democratizing and facilitating access to life saving vaccines, diagnostics and drugs is one of our main mission in the next decade! 💪👌

[Nonacus @NonacusLtd]

🎉 Exciting News! Yesterday marked a significant milestone for us with the official opening of our new Birmingham HQ. We were delighted to have the distinguished presence of Angela Douglas MBE, Deputy Chief Scientific Officer for NHS England, leading the ribbon-cutting ceremony.

[Nonacus @NonacusLtd]

In our latest blog post we explore the subject of targeted NGS and explain the steps involved in a targeted NGS assay, as well as covering why targeted NGS is necessary for cell-free DNA (cfDNA) samples.

https://t.co/bFumnCnUjI

[Gregory Maes @GregBioGenomics]

Great new paper on Bladder Cancer and use of ut/ctDNA for earlier detection, stratification & surveillance. This is exactly the application of @NonacusLtd new Bladder Cancer test. Lear all about it here: https://t.co/9IPM2U5HLJ

[Hegel Hernandez @Hegel_MD_PhD]

@NatureRevUrol current and future use of utDNA & ctDNA to improve diagnosis, risk stratification, monitoring, and surveillance 🎯 🚨@OncoAlert

🤓Read the full review here👇
https://t.co/PWqWHQLrY8

#MedicalOncology #Genomics #PrecisionMedicine #liquidbiopsy

[Gregory Maes @GregBioGenomics]

@ItsFrogday @donaldmcknight2 Yep Lorenzo, being in biotech industry now, it's how it goes. Quotes last for 1 or 2 months, but main reason is March= start of new pricing for 2023. Most Costs of Goods for kits increased in 2022 unfortunately... Still worth negotiating in the name of large account like JCU! 🤞

[Nonacus @NonacusLtd]

Hello from EACR Molecular Pathology. If you are attending, make sure to drop by our stand to learn about our molecular diagnostic solutions.We will also be showing a poster tomorrow (13:25 – 14:55 in the Main Hall) presented by Nonacus Senior Research Scientist Dr James Hassall.

[Gregory Maes @GregBioGenomics]

@Inge_Smeers Go Go Inge ! 💪👌 #singlecellforce